Gufic-BioSciences-Ltd Stock/Share Prices, Buy and Sell Gufic-BioSciences-Ltd NSE Stocks

Market Snapshot

BSE Sensex: 49792.12 0.80%
BSE 500: 19202.91 0.81%
BSE 200: 6201.23 0.82%
BSE 100: 14792.51 0.83%
BSE Mid-Cap: 19156.32 1.08%
BSE Small-Cap: 18743.39 0.58%
BANKEX: 36836.73 0.29%
BSE IT Sector: 26566.23 1.75%
Nifty 50: 14644.7 0.85%
Nifty 500: 12078.35 0.81%
Nifty 200: 7585.95 0.84%
Nifty 100: 14751.3 0.81%
Nifty Midcap 100: 22197.4 1.04%
Nifty Small 100: 7439.2 0.59%
Nifty IT: 26619.7 2.21%
Nifty PSU Bank: 1980.8 2.07%

News:

HDFC AMC Q3 PAT rises 5% to Rs...
Bajaj Finance Q3 PAT declines ...
Ramco Systems, HERE join hands...
Hindustan Zinc Q3 PAT jumps 36...
Tata Communications Ltd leads ...

Gufic BioSciences Ltd NSE / BSE
Pharmaceuticals, Small Cap

Invest

20 Jan 2021 | 04:14 PM

121.80

-0.50 (-0.41%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

97.73%

Return (1Y)

Beaten Nifty 50 by 77.93%
More Volatile

4.19%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.21%
Consistent Performer

7/12

Months

beaten Nifty 50
AxisDirect View

No View

52 Week High-Low

137

News & Announcements

Gufic BioSciences receives NCLT, Ahmedabad bench approval for scheme of amalgamaiton
16 days ago

Gufic BioSciences receives NCLT, Ahmedabad bench approval for scheme of amalgamaiton

04 - Jan - 2021 12:00 AM | 16 days ago

Gufic BioSciences announced that the scheme of amalgamation of Gufic Lifesciences (transferor company) with Gufic Biosciences (transferee company) and their respective shareholders and creditors has been sanctioned by the National Company Law Tribunal (NCLT), Ahemedabad bench vide its order dated 31 December 2020. The scheme is subject to the final order of the proceedings preferred by the transferee company before the NCLT, Mumbai bench.
Powered by Capital Market - Live News
Gufic BioSciences standalone net profit rises 279.77% in the September 2020 quarter
68 days ago

Gufic BioSciences standalone net profit rises 279.77% in the September 2020 quarter

13 - Nov - 2020 12:00 AM | 68 days ago

Net profit of Gufic BioSciences rose 279.77% to Rs 16.33 crore in the quarter ended September 2020 as against Rs 4.30 crore during the previous quarter ended September 2019. Sales rose 39.89% to Rs 120.35 crore in the quarter ended September 2020 as against Rs 86.03 crore during the previous quarter ended September 2019.
Particulars Quarter Ended
Sep. 2020 Sep. 2019 % Var.
Sales 120.35 86.03 40
OPM % 21.30 11.84 -
PBDT 24.49 8.30 195
PBT 22.01 5.65 290
NP 16.33 4.30 280
Powered by Capital Market - Live News
Gufic BioSciences to hold board meeting
77 days ago

Gufic BioSciences to hold board meeting

04 - Nov - 2020 12:00 AM | 77 days ago

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 12 November 2020.
Powered by Capital Market - Live News
Gufic BioSciences schedules AGM
91 days ago

Gufic BioSciences schedules AGM

21 - Oct - 2020 12:00 AM | 91 days ago

Gufic BioSciences announced that the 36th Annual General Meeting (AGM) of the company will be held on 11 November 2020.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Gufic BioSciences Ltd has decreased by -90.28% since past 3 Months
MF shareholding in Gufic BioSciences Ltd has increased by 10.36% since past 3 Months
FII shareholding in Gufic BioSciences Ltd has decreased by -90.99% since past 1 Year
MF shareholding in Gufic BioSciences Ltd has increased by 11.87% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2020	Sep. 2019	% Var.
Sales	120.35	86.03	40
OPM %	21.30	11.84	-
PBDT	24.49	8.30	195
PBT	22.01	5.65	290
NP	16.33	4.30	280

General Notifications

My Notifications

Research Notifications

Gufic BioSciences Ltd NSE / BSE Pharmaceuticals, Small Cap

121.80 -0.50 (-0.41%)

News & Announcements

Price vs Volume

Stock Trivia

Gufic BioSciences Ltd NSE / BSE
Pharmaceuticals, Small Cap

121.80

-0.50 (-0.41%)